| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | -98.0% |
| R&D Expense | $71.9M | +4.9% |
| SG&A Expense | $20.6M | +12.4% |
| Operating Income | -$176.1M | -619.3% |
| Pre-tax Income | -$170.3M | -657.3% |
| Income Tax | $0 | -100.0% |
| Net Income | -$169.8M | -640.6% |
| EPS (Basic) | -$26.75 | — |
| EPS (Diluted) | -$26.75 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $189.8M | +430.6% |
| Accounts Receivable | $1.7M | -89.6% |
| Current Assets | $210.7M | +246.3% |
| Total Assets | $214.8M | +220.4% |
| Current Liabilities | $49.6M | -26.5% |
| Total Liabilities | $51.5M | -31.6% |
| Stockholders' Equity | $163.3M | +2089.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$176.5M | -687.0% |
| Capital Expenditures | $129K | -74.5% |
| Investing Cash Flow | -$129K | +74.5% |
| Financing Cash Flow | $337.1M | +1197.2% |
| Free Cash Flow | -$176.7M | -670.2% |